SFI
ASMB icon

Susquehanna Fundamental Investments’s Assembly Biosciences ASMB Stock Holding History

Susquehanna Fundamental Investments’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-1,360
Closed -$268K – 1491
2020
Q3 		$268K Buy
+1,360
New +$342K 0.01% 1097

Other funds holding ASMB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
AIM
Alerce Investment Management Chicago, Illinois $56.8M AUM 31.17% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

Susquehanna Fundamental Investments's ASMB Position: Q4 2020 in Review

Susquehanna Fundamental Investments sold out of Assembly Biosciences (ASMB) in Q4 2020, closing a stake of 1,360 shares — an estimated $268K sold.

Susquehanna Fundamental Investments first reported a position in ASMB in Q3 2020 and held it in 1 quarter. The position peaked at $268K in Q3 2020. 109 funds tracked by Wall St. Rank hold ASMB as of Q4 2020.

  • Susquehanna Fundamental Investments reported no remaining Assembly Biosciences position as of Q4 2020 after selling out during the quarter.
  • Susquehanna Fundamental Investments sold 1,360 Assembly Biosciences shares in Q4 2020, an estimated $268K.
  • Susquehanna Fundamental Investments first reported a position in Assembly Biosciences in Q3 2020 and held it in 1 quarter.
  • Susquehanna Fundamental Investments's Assembly Biosciences position peaked at $268K in Q3 2020.
  • 109 funds tracked by Wall St. Rank held Assembly Biosciences as of Q4 2020.

Based on Susquehanna Fundamental Investments's 13F filing for Q4 2020, filed 16 Feb 2021.